Citations

Showing 10 of 108104 citations.

CBMT-09. ESTABLISHMENT AND IN VITRO CHARACTERIZATION OF A SPORADIC PEDIATRIC ATYPICAL MENINGIOMA CELL LINE
Kaptzan, Tatiana, Peterson, Timothy E., Jentoft, Mark E. , Brown, Desmond , Daniels, David J.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi34-vi34

10.1093/neuonc/noy148.128 Get It

NIMG-17. UTILIZING MACHINE LEARNING FOR PREDICTIVE MODELING OF SEIZURE PRESENTATION IN GLIOMA PATIENTS
Ranjbar, Sara , Johnston, Sandra K. , Hu, Leland , Whitmire, Paula , Swanson, Kristin R. , Swanson, Kristin R , Khurana, Aditya , Sharma, Akanksha

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi179-vi179

10.1093/neuonc/noy148.744 Get It

PDCT-04. PHASE 1 TRIAL OF WEE1 KINASE INHIBITOR AZD1775 COMBINED WITH RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP PHASE 1 PILOT CONSORTIUM (ADVL1217)
Mueller, Sabine , Yang, Xiaodong, Pal, Sharmistha , Ermioian, Ralph, Fox, Elizabeth , Gajjar, Amar , Prem, Komal, Weigel, Brenda J. , Haas‐Kogan, Daphne A. , Yang, Xiaodong, Minard, Charles G. , Liu, Xiaowei , Reid, Joel M.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi201-vi201

10.1093/neuonc/noy148.834 Get It

CMET-24. NEXT-GENERATION EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR LEPTOMENINGEAL CARCINOMATOSIS
Grimsrud, Kate W., Mrugała, Maciej M.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi58-vi59

10.1093/neuonc/noy148.236 Get It

RDNA-06. A NOVEL ROLE OF SGEF IN MEDIATING GBM CELL SURVIVAL BY MODULATING THE DNA DAMAGE REPAIR MECHANISM
Tuncali, Serdar, Sereduk, Christopher, Ensign, Shannon P. Fortin , Kloss, Jean , Loftus, Joseph C. , Ensign, Shannon P. Fortin , Sereduk, Chris , Sarkaria, Jann N. , Tran, Nhan L.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi222-vi223

10.1093/neuonc/noy148.922 Get It

DDIS-01. THE ANTIBODY-DRUG CONJUGATE ABT-414 DEMONSTRATES SINGLE-AGENT ANTI-CANCER ACTIVITY ACROSS A PANEL OF GBM PATIENT-DERIVED XENOGRAFTS
Marin, Bianca M. , Hu, Zeng, Carlson, Brett L. , Marin, Bianca M , Mladek, Ann C. , Burgenske, Danielle M. , He, Lihong , Bakken, Katrina K. , Schroeder, Mark A. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi69-vi69

10.1093/neuonc/noy148.280 Get It

CADD-57. THE EFFICACY OF THERAPY WITH ABT-414, AN EGFR-TARGETING ADC, IS POTENTIALLY ALTERED BY HETEROZYGOUS DELETION OF THE ENDOCYTIC TRAFFICKING REGULATOR RBSN
Muller-Greven, Gaëlle, Marin, Bianca M. , Carlin, Cathleen R. , Reilly, Edward B. , Bredel, M., Gladson, Candece L. , Marin, Bianca M , Müller-Greven, Gaëlle, Lee, Jeongwu , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi283-vi284

10.1093/neuonc/noy148.1182 Get It

RDNA-04. POTENTIAL MECHANISM OF TEMOZOLOMIDE-MEDIATED RADIO-SENSITIZATION IN MGMT HYPERMETHYLATED GLIOBLASTOMA CELLS
Kitange, Gaspar J. , Smith, Emily, Gupta, Shiv K. , Sarkaria, Jann N.

Mayo Clinic

Neuro-Oncology | November 5, 2018 | Volume: 20 | Issue: suppl_6 | Pages: vi222-vi222

10.1093/neuonc/noy148.920 Get It